Can the MMP-9/NGAL ratio be a diagnostic biomarker for the diagnosis of endometrioma in infertile patients?
ObjectiveIn this study, we aimed to investigate whether serum NGAL, MMP-9 and the MMP-9/NGAL ratio, which are inflammatory markers used for the diagnosis and follow-up of some diseases, can be used as diagnostic and follow-up markers for the diagnosis of endometriomas in infertile patients.MethodsFo...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1624717/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849412097811677184 |
|---|---|
| author | Batuhan Turgay Batuhan Özmen Harun Kılıçkıran Yavuz Emre Şükür Murat Sönmezer Bülent Berker Cem Somer Atabekoğlu Ruşen Aytaç |
| author_facet | Batuhan Turgay Batuhan Özmen Harun Kılıçkıran Yavuz Emre Şükür Murat Sönmezer Bülent Berker Cem Somer Atabekoğlu Ruşen Aytaç |
| author_sort | Batuhan Turgay |
| collection | DOAJ |
| description | ObjectiveIn this study, we aimed to investigate whether serum NGAL, MMP-9 and the MMP-9/NGAL ratio, which are inflammatory markers used for the diagnosis and follow-up of some diseases, can be used as diagnostic and follow-up markers for the diagnosis of endometriomas in infertile patients.MethodsForty-five patients with unexplained infertility and 45 infertile patients with endometriomas were included in the study. Patients with endometriomas of at least 3 cm in size were included in the study. NGAL and MMP-9 levels in venous blood samples and the MMP-9/NGAL ratios of the unexplained infertility and endometrioma groups and the preoperative and postoperative results of the endometrioma group were compared.ResultsThe mean blood NGAL and MMP-9 levels in the endometrioma and unexplained groups were 22.0 ± 4.0 ng/ml and 25.4 ± 4.9 ng/ml and 43.7 ± 8.0 ng/ml and 39.3 ± 10.7 ng/ml, respectively, and all the results were statistically significant (p=0.001; p=0.012). The mean blood levels of NGAL and MMP-9 in endometriomas and the same patients at three months after surgery were 24.9 ± 4.9 ng/ml and 27.0 ± 4.9 ng/ml and 43.9 ± 7.3 ng/ml and 36.7 ± 8.7 ng/ml, respectively (p=0.179; p=0.006). The mean ratios of MMP-9/NGAL in the endometrioma, unexplained and postoperative groups were 2.0 ± 0.2, 1.5 ± 0.2 and 1.4 ± 0.2, respectively. All these results were significantly different between the endometrioma-unexplained group and the endometrioma-postoperative group (p=0.001; p=0.001). When we performed a ROC curve analysis for the presence of endometrioma, an MMP-9/NGAL ratio greater than 1.75 had 86.1% sensitivity and 84% specificity in indicating the presence of endometrioma (AUC=0.898). There was a positive correlation between the VAS score and the MMP-9/NGAL ratio.ConclusionsInterestingly, the NGAL blood NGAL level was lower in the endometrioma group than in the control group. The MMP-9/NGAL ratio can be useful in the diagnosis of endometrioma, and this ratio reflects the clinical findings of the disease. |
| format | Article |
| id | doaj-art-1d28de3aaa6a4867a2df491bac32a823 |
| institution | Kabale University |
| issn | 1664-2392 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Endocrinology |
| spelling | doaj-art-1d28de3aaa6a4867a2df491bac32a8232025-08-20T03:34:33ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922025-07-011610.3389/fendo.2025.16247171624717Can the MMP-9/NGAL ratio be a diagnostic biomarker for the diagnosis of endometrioma in infertile patients?Batuhan Turgay0Batuhan Özmen1Harun Kılıçkıran2Yavuz Emre Şükür3Murat Sönmezer4Bülent Berker5Cem Somer Atabekoğlu6Ruşen Aytaç7Department of Obstetrics and Gynecology, Reproductive Endocrinology, School of Medicine, Ankara University, Ankara, TürkiyeDepartment of Obstetrics and Gynecology, Reproductive Endocrinology, School of Medicine, Ankara University, Ankara, TürkiyeHatay Dörtyol State Hospital Department of Obstetrics and Gynecology, Hatay, TürkiyeDepartment of Obstetrics and Gynecology, Reproductive Endocrinology, School of Medicine, Ankara University, Ankara, TürkiyeDepartment of Obstetrics and Gynecology, Reproductive Endocrinology, School of Medicine, Ankara University, Ankara, TürkiyeDepartment of Obstetrics and Gynecology, Reproductive Endocrinology, School of Medicine, Ankara University, Ankara, TürkiyeDepartment of Obstetrics and Gynecology, Reproductive Endocrinology, School of Medicine, Ankara University, Ankara, TürkiyeDepartment of Obstetrics and Gynecology, Reproductive Endocrinology, School of Medicine, Ankara University, Ankara, TürkiyeObjectiveIn this study, we aimed to investigate whether serum NGAL, MMP-9 and the MMP-9/NGAL ratio, which are inflammatory markers used for the diagnosis and follow-up of some diseases, can be used as diagnostic and follow-up markers for the diagnosis of endometriomas in infertile patients.MethodsForty-five patients with unexplained infertility and 45 infertile patients with endometriomas were included in the study. Patients with endometriomas of at least 3 cm in size were included in the study. NGAL and MMP-9 levels in venous blood samples and the MMP-9/NGAL ratios of the unexplained infertility and endometrioma groups and the preoperative and postoperative results of the endometrioma group were compared.ResultsThe mean blood NGAL and MMP-9 levels in the endometrioma and unexplained groups were 22.0 ± 4.0 ng/ml and 25.4 ± 4.9 ng/ml and 43.7 ± 8.0 ng/ml and 39.3 ± 10.7 ng/ml, respectively, and all the results were statistically significant (p=0.001; p=0.012). The mean blood levels of NGAL and MMP-9 in endometriomas and the same patients at three months after surgery were 24.9 ± 4.9 ng/ml and 27.0 ± 4.9 ng/ml and 43.9 ± 7.3 ng/ml and 36.7 ± 8.7 ng/ml, respectively (p=0.179; p=0.006). The mean ratios of MMP-9/NGAL in the endometrioma, unexplained and postoperative groups were 2.0 ± 0.2, 1.5 ± 0.2 and 1.4 ± 0.2, respectively. All these results were significantly different between the endometrioma-unexplained group and the endometrioma-postoperative group (p=0.001; p=0.001). When we performed a ROC curve analysis for the presence of endometrioma, an MMP-9/NGAL ratio greater than 1.75 had 86.1% sensitivity and 84% specificity in indicating the presence of endometrioma (AUC=0.898). There was a positive correlation between the VAS score and the MMP-9/NGAL ratio.ConclusionsInterestingly, the NGAL blood NGAL level was lower in the endometrioma group than in the control group. The MMP-9/NGAL ratio can be useful in the diagnosis of endometrioma, and this ratio reflects the clinical findings of the disease.https://www.frontiersin.org/articles/10.3389/fendo.2025.1624717/fullMMP-9NGALendometriomalaparoscopyinfertility |
| spellingShingle | Batuhan Turgay Batuhan Özmen Harun Kılıçkıran Yavuz Emre Şükür Murat Sönmezer Bülent Berker Cem Somer Atabekoğlu Ruşen Aytaç Can the MMP-9/NGAL ratio be a diagnostic biomarker for the diagnosis of endometrioma in infertile patients? Frontiers in Endocrinology MMP-9 NGAL endometrioma laparoscopy infertility |
| title | Can the MMP-9/NGAL ratio be a diagnostic biomarker for the diagnosis of endometrioma in infertile patients? |
| title_full | Can the MMP-9/NGAL ratio be a diagnostic biomarker for the diagnosis of endometrioma in infertile patients? |
| title_fullStr | Can the MMP-9/NGAL ratio be a diagnostic biomarker for the diagnosis of endometrioma in infertile patients? |
| title_full_unstemmed | Can the MMP-9/NGAL ratio be a diagnostic biomarker for the diagnosis of endometrioma in infertile patients? |
| title_short | Can the MMP-9/NGAL ratio be a diagnostic biomarker for the diagnosis of endometrioma in infertile patients? |
| title_sort | can the mmp 9 ngal ratio be a diagnostic biomarker for the diagnosis of endometrioma in infertile patients |
| topic | MMP-9 NGAL endometrioma laparoscopy infertility |
| url | https://www.frontiersin.org/articles/10.3389/fendo.2025.1624717/full |
| work_keys_str_mv | AT batuhanturgay canthemmp9ngalratiobeadiagnosticbiomarkerforthediagnosisofendometriomaininfertilepatients AT batuhanozmen canthemmp9ngalratiobeadiagnosticbiomarkerforthediagnosisofendometriomaininfertilepatients AT harunkılıckıran canthemmp9ngalratiobeadiagnosticbiomarkerforthediagnosisofendometriomaininfertilepatients AT yavuzemresukur canthemmp9ngalratiobeadiagnosticbiomarkerforthediagnosisofendometriomaininfertilepatients AT muratsonmezer canthemmp9ngalratiobeadiagnosticbiomarkerforthediagnosisofendometriomaininfertilepatients AT bulentberker canthemmp9ngalratiobeadiagnosticbiomarkerforthediagnosisofendometriomaininfertilepatients AT cemsomeratabekoglu canthemmp9ngalratiobeadiagnosticbiomarkerforthediagnosisofendometriomaininfertilepatients AT rusenaytac canthemmp9ngalratiobeadiagnosticbiomarkerforthediagnosisofendometriomaininfertilepatients |